A new license to adapt EORTC questionnaires into electronic versions
15 Apr 2021
As of 15 May 2021, the EORTC will introduce a new license for any Electronic Outcome Assessment (eCOA) provider or other entity (e.g. CRO or pharmaceutical company) adapting – or “migrating” – the EORTC Quality of Life Group questionnaires and modules into electronic versions (e-versions) and making these e-versions available for use in clinical trials or other studies. This license is subject to a royalty fee when the e-version(s) will be used in commercial trials or studies. When adapting the questionnaires into an in e-version for use in academic trials, the license will still be required, however no royalty fee will be charged.
There are two types of licenses:
- The “Study Solution” where a provider will adapt an EORTC questionnaire for a single study; or
- The “Library Solution” where a provider will create a “library” of e-versions of EORTC Quality of Life Group Questionnaire, available for use in clinical trials and studies.
For any further queries regarding these licensing solutions, their scope and fees, please contact EORTC at: qol.contracts@eortc.org
With this new license, the EORTC aims to improve the quality and consistency of the e-versions of its questionnaires.
We thank you for your understanding of this evolution of EORTC processes and we look forward to a continued collaboration.
Related News
Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023
6 Dec 2023
EORTC Quality of Life measures integrated in CDISC
20 Nov 2023
EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma
7 Nov 2023
Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia
31 Oct 2023
New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023
20 Oct 2023
EORTC & the Menarini Group Launch New Clinical Trial in Early-Stage Breast Cancer
19 Oct 2023
EORTC’s presence at ESMO 2023
17 Oct 2023
The EU funded project LEGATO officially started
4 Oct 2023
EORTC strategic meeting with Middle Eastern Ambassadors
26 Sep 2023
EORTC Quality of Life Group projects to be presented at ISOQOL 2023
22 Sep 2023